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1. Introduction
   Toxoplasmosis is a parasitic disease of a worldwide distribution, 
endangering about one-third of human population. Due to its 
possible development into congenital infection and sequelae in 
the newborn, the disease must be timely and properly diagnosed. 
The occurrence of infection during the first trimester of 
pregnancy can expose the growing fetus to serious morbidity 
and mortality. Whereas, acquiring toxoplasmosis at the last 
trimester may lead to the development of clinical symptoms of 
congenital infection in exposed children during the first decade 
of their lives. It is, therefore, vital to recognize toxoplasmosis 
and its acute and chronic stages in order to treat the infection 
or restrain its effects, specifically during the pregnancy[1]. 
Although serological methods for detection of anti-Toxoplasma 
immunoglobulin G (IgG), immunoglobulin M (IgM), and 
immunoglobulin A antibodies provide useful diagnostic tools, 
there are some limitations. For example, ocular manifestation 
of congenital toxoplasmosis in children and adolescents is not 
always accompanied with increased IgG titers. In some cases, 
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SPSS 17.0. 
Results: Anti-Toxoplasma tests of IgM and IgG were positive in 9 and 86 samples respectively. 
Also, a borderline IgM was detected in 2 suspected samples. In addition, among all positive 
and suspected samples, 79 cases indicated high titers of IgG avidity, 7 cases were of low 
titers and 1 case was of a borderline titer. The prevalence of anti-Toxoplasma antibodies was 
20%. The sera which showed high avidity index was obtained from patients at chronic phase 
of infection (92%) while those which showed low avidity levels were from patients at acute 
toxoplasmosis (77.7%).  
Conclusions: This study clearly showed that acute and chronic phases of toxoplasmosis could 
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and newly acquired infections.
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Toxoplasma IgM antibody can be detected even after a few years 
following primary infections. The antibody can, also, be recognized 
in patients with rheumatoid factors and antinuclear antibodies. 
However, it has been shown that as the infection becomes older, 
the antibody epitope bond becomes stronger. Also, ELISA test can 
be applied to detect specific IgG avidity at various toxoplasmosis 
phases, so that low and high levels of IgG avidity can indicate acute 
and chronic phases of toxoplasmosis respectively. Therefore, a high 
IgG avidity can serve as an indication of a chronic toxoplasmosis, 
whereas a low avidity can serve as points at a recent infection of 
3–5 months old[2-4]. This study aimed to evaluate IgG avidity test 
for detection of acute toxoplasmosis in the pregnant women referring 
to therapeutic centers of Karaj City in 2014.
2. Materials and methods
2.1. Collection of serum samples 
   To undertake this descriptive cross sectional research, 468 serum 
samples were randomly obtained from beta-human chorionic 
gonadotropin-positive women referring to therapeutic centers 
in Alborz Province. The samples were then transferred to the 
parasitology laboratory of the faculty of Para Medical Sciences 
of Iran University of Medical Sciences where they were kept 
under standard conventional conditions for < 2 h before being 
centrifuged at 3 000 r/min for 15 min. The isolated sera were then 
frozen as per Alicot method and stored at−20 °C until used. Informed 
consents of all women involved in this study were ensured 
beforehand. The patients were asked to fill in a questionnaire on 
their demographic characteristics. The procedures of this study 
were also approved by the Ethical Committee of the Faculty of 
Medicine (Iran University of Medical Sciences). At first, ELISA 
test was applied to examine all sera for anti-Toxoplasma IgG and 
IgM antibodies according to manufacturer’s instruction (Dia-Pro, 
Milan, Italy). The Toxoplasma-IgG was measured quantitatively 
but Toxoplasma-IgM was determined against an index reported by 
computing the cutoff point. The sera samples were then divided 
into three groups: Group I samples were obtained from patients 
suffering from acute toxoplasmosis; Group II samples were 
obtained from patients with chronic toxoplasmosis and Group 
III samples were obtained from patients showing borderline 
antibodies.  
2.2. ELISA test
   ELISA technique was used to measure the levels of anti-
Toxoplasma IgG and IgM at the start of pregnancy according to 
manufacturer’s instruction (Vircell Microbiology Company). 
 2.3. Avidity ELISA
   Avidity tests were performed using Euroimmun kit as follows: sera 
were diluted before being added at 100 μL to microplates coated with 
Toxoplasma antigen. The antigen-antibody complex of microplate 
was then received concentrated urea solution (8 mol/L). The excess 
antibody was washed from the microplates and labeled anti-IgG 
antibody was supplemented. The microplates were incubated for 30 
min and re-washed before addition of substrate solution. Sulfuric 
acid was final added to stop the reactions in the microplates. The 
measurement of optical density (OD) was performed at 450 nm 
against differential absorption at 600 nm. The avidity was obtained 
from the following formula[4-6]:
 
× 100Avidity index (%) = 
OD of the sample treated with urea 
– OD of the blank
OD of the sample treated 
without urea
2.4. Statistical analysis
   The obtained data underwent statistical analysis using descriptive 
methods. The data were also subjected to Chi-square tests. 
Differences between variants were considered significant at P ≤ 
0.05. Computation of diagnostic values was performed using SPSS 
version 17.
3. Results
   For the purpose of this study, the avidity was classified into three 
levels: low avidity (≤ 40), high avidity (≥ 60) and borderline (40 
≤ avidity  index (AI) ≤ 60). A total of 468 samples were evaluated 
by IgG ELISA method of which 86 samples were positive, 382 
samples were negative. No borderline sample was detected. The 
same samples were also evaluated by IgM ELISA method of which 
9 were positive, 457 were negative and 2 were borderline. Then, 
IgG avidity tests were carried out for all IgG and IgM positive 
and borderline samples. The results showed 79 samples to be high 
avidity, 7 to be low avidity and 1 to be borderline value.
   The samples were categorized into 3 sera groups: Group I included 
9 sera from patients with acute toxoplasmosis, in which specific 
IgM antibodies were detected and the patients of this group showed 
lymphadenopathy signs; Group II was formed from 86 sera from 
patients with chronic toxoplasmosis and these sera also contained 
specific IgG antibodies and Group III included 2 sera samples from 
patients with borderline IgM antibodies. In addition, the prevalence 
of anti-Toxoplasma antibodies was 20%. Out of 9 sera, 7 samples 
(77.7%) from patients with acute infections indicated low avidity 
levels and 79 out of 86 (sera 92%) from patients with chronic 
infections showed high avidity index. One sera had a borderline 
range of AI. By analyzing the data, we observed a significant 
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correlation between high IgM titers and low avidity of IgG (P < 
0.05). But, no significant correlation was observed between IgG 
level and avidity index in Group II (P > 0.05). As per our data, 
measurement of IgG avidity can clearly differentiate between the 
acute and chronic phases of toxoplasmosis (Table 1). 
Table 1
Comparative analysis of measurement of IgG, IgM and IgG avidity.
Parameters Total Borderline Negative Positive
IgG test 468 0 (0.0%) 382 (81.6%) 86 (18.4%)
IgM test 468 2 (0.4%) 457 (97.6%) 9 (1.9%)
IgG avidity   87 1 (1.1%)   79 (90.8%) 7 (8.1%)
4. Discussion
   Toxoplasmosis is a worldwide parasitic infection with variable 
prevalence in different countries. Various techniques have been 
developed for Toxoplasma diagnosis such as anti-Toxoplasma 
antibodies detection, mouse inoculation and histological examination 
of tachyzoites[7]. 
   On the other hand, several screening tests of mainly serology 
are used including indirect immunofluorescent antibody test, latex 
agglutination, indirect hemagglutination and ELISA[7,8]. In our study, 
we used ELISA test which is of high sensitivity and specificity. 
ELISA is frequently performed in many medical centers in our 
country for detection of anti-Toxoplasma antibodies. The clinicians 
prefer ELISA because of its excellent sensitivities and specificities, 
rapid accessibility and low cost. Hedman et al. firstly suggested a 
new diagnostic method in 1989 which was later called avidity test[9]. 
The method measures the affinity of antibodies of immunoglobulins 
bonding with Toxoplasma gondii polyvalent antigens under high 
urea concentration to differentiate immunoglobulin of high affinity. 
This method is now applied to evaluate the avidity of Toxoplasma 
IgG. A high avidity (AI ≥ 60%) serves as an indication of an old 
Toxoplasma infection acquired 3 months before the sampling, while 
a borderline avidity (40% < AI < 60%) indicates that the disease 
is at an indeterminate period. On the other hand, a low avidity 
(AI ≤ 40%) shows that onset of infection was within the last 3 
months. Different avidity titers were reported by various authors 
as cutoff levels. For instance, an avidity level lower than 20% was 
suggested to be considered as a low avidity. Whereas, Yasodhara 
et al. suggested a low avidity to be below 30%[10]. Findal as well 
as Montoya and Liesenfeld agreed on a low avidity value of less 
than 40%[5,7]. By studying 37 pregnant women in 2004, researchers 
found IgG avidity varing between a low level of 10.8% and a high 
level of 57.2% at the beginning of pregnancy[8,9]. A pre-pregnancy 
negative IgG test and a post-pregnancy positive one are vital in 
diagnosing Toxoplasma infection. Since some pregnant women 
have not undertaken toxoplasmosis, other agents, rubella (also 
known as German measles), cytomegalovirus and herpes simplex 
screening tests prior to pregnancy, the avidity test becomes a high 
value to discover active toxoplasmosis during pregnancy. A number 
of researches that examined pregnant women have confirmed the 
validity of our results. However, in some cases, a high avidity of 
45.8% (IgG+, IgM+) can be attributed to either a high half-life of 
IgM or the existence of rheumatoid factor. Therefore, avidity test can 
assist in making decision for treating toxoplasmosis if a differential 
diagnosis is performed on time to detect active infections. We found 
that 44% of pregnant women were tested positive for IgG and 
negative for IgM while showing high avidity values. Our results 
indicated that in Alborz Province, the level of Toxoplasma infection 
in pregnant women is high due to their contact with Toxoplasma 
parasite before pregnancy. Other studies showed that 55% of the 
pregnant women were positive for IgG and IgM whereas 7.1% 
of them were of low avidity levels in the first 2 to 4 months of 
pregnancy. This can be taken as indication for prevalence of active 
infections among these pregnant women[6,10,11]. 
   However, Morris and Croxson stated that by measuring IgG 
avidity, they were able to distinguish between the stages of 
toxoplasmosis[12]. To the contrary, Remington et al. believed that 
measuring IgG avidity cannot prove acute toxoplasmosis unless 
it is confirmed by IgM ELISA test[13]. This has been emphasized 
by many investigators who proposed IgM detection for acute 
infection diagnosis. However, the detection of reactivated 
toxoplasmosis in immunocompromised patients can be considered 
as one of the limitations of IgG avidity method[13,14]. The 
elevated level of Toxoplasma IgG can discover recent infections 
but its monitoring might be harmful for the fetus as it requires 
a long period of time. However, toxoplasmosis must be timely 
diagnosed and treated during pregnancy to ensure protection of 
the fetus from disease and its consequences[15].
   In our study, 382 pregnant women (81.6%) were negative 
for anti-Toxoplasma IgG which indicated that they were not 
previously exposed to the disease or IgG of sera samples at 
undetectable level. Also, 86 women (18.4%) were positive for 
anti-Toxoplasma IgG which showed that they were previously in 
contact with the agent of infection and had immunity due to their 
chronic infections. No intermediate titer of IgG was observed 
throughout this study.
   IgM anti-Toxoplasma serum samples of all mothers were tested 
which showed that 457 patients (97.6%) were found negative, 
9 mothers were positive and 2 mothers had uncertain results. 
Positive cases or intermediate (border line) might serve as 
indication of the current contact with the infection and the risks. 
This may harbor as irreparable complications for the mother and 
fetus. All mothers whose tests were positive or borderline for 
anti-Toxoplasma IgM, showed positive results for Toxoplasma 
IgG except for a 28-year-old first-time mother whose IgM titer 
was about 1.06 (positive) and IgG titer was 3.00 (negative). After 
carrying out IgG avidity tests on samples of mothers’ sera which 
were either positive or borderline for Toxoplasma IgG and IgM 
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titers, 79 mothers were found of high affinity and considered to 
have chronic infection (previous encounter) which presented no 
serious risk to the mother and fetus. Also, 7 mothers had low affinity 
and therefore they suffered from acute infection of high risk to the 
mother and fetus. The only borderline case was referred to the 
responsible physician for proper decision on repeating her tests 
or prescribing her further supplemental tests.
   A total of 11 mothers were tested positive or suspected for anti-
Toxoplasma IgM test, only seven were of low IgG avidity test 
and their IgM tests were confirmed. Given the high affinity in 
one case, the possibility of active infection of the mother was 
ruled out. Also, one case with acute infection and borderline 
affinity (28-year-old mother in her first trimester whose IgM test 
was positive) was subjected to further complementary tests. In 
two cases with suspected IgM tests, acute risk of infection was 
rejected on the basis of IgG avidity test and high affinity. 
   In conclusion, our study indicated that application of both IgM-
ELISA test and IgG avidity-ELISA test can assist in differentiation 
between acute and chronic phases of toxoplasmosis. The 
avidity test provides an essential diagnostic tool for treating 
toxoplasmosis if it is concurrently applied with a differential test 
to distinguish active and chronic infection of this parasite. To 
reduce the consequences of toxoplasmosis, it may be appropriate 
to monitor seropositivity in mothers before and during pregnancy.
   Sometimes, further study is also required, including the 
sampling of the fetus (amniocentesis), which is a decisive way in 
parasitological study, but it is not usually welcomed by patients 
and their physicians due to potential risks of amniotic fluid 
sampling. It is, therefore, recommended that in cases of suspected 
toxoplasmosis, a reliable test called IgG avidity test can be used 
instead of doing two anti-Toxoplasma IgM and IgG tests. It will 
save time and expenditure when screening toxoplasmosis in 
pregnancy. Additional tests such as molecular techniques should 
be used only in cases that IgG avidity test involves risks to 
mother and fetus[12,13]. 
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